Empyrean Energy (AIM:EME), the AIM-listed oil and gas explorer with interests in Australia, Indonesia and the United States, said the completed transaction triggers a $4 million payment from Nations, the second tranche of a $16 million cash consideration.
A further $7 million is payable once commercial production begins at the Mako Gas Field, operated by Conrad Asia Energy's subsidiary West Natuna Exploration.
Conrad has confirmed Mako is now fully funded, with development activities underway and first gas targeted for the fourth quarter of 2027.
The deal reduces Empyrean's funding exposure to the project while preserving its economic interest, held through a special purpose vehicle, WNEL Holdings, entitling it to 8.5% of all cash payments to West Natuna Exploration including Mako gas sales revenue.
That interest stems from a Shareholders Agreement executed after Empyrean settled historical cash call arrears with Conrad in February, with Indonesia's Ministry of Energy and Mineral Resources approval now secured as the final regulatory condition.
Empyrean is also finalising a separate settlement with Conrad covering a 50% cash call payment of $353,388 plus associated taxes and costs.
Once the remaining steps complete, including issuance of the 8.5% equity interest in WNEL Holdings, Conrad will hold a 22.875% operated stake in the Duyung PSC.
"Mako is now fully funded and development activities are well underway, with first gas targeted for Q4 2027," said chief executive Gaz Bisht, adding the deal gives shareholders exposure to a "potentially material future cash-generating asset" without further development funding requirements.
News Intelligence what this means for the company
Empyrean has cleared the final regulatory hurdle for its Mako Gas Field stake, with Indonesia's MEMR approval now secured and the Nations farm-down completed, triggering a $4 million cash payment and unlocking full funding for the project. The company retains an 8.5% economic interest in Mako through WNEL Holdings without further development capital exposure, positioning it to receive $16 million in tranches ($5m upon MEMR approval, $4m within 30–45 days, and $7m on first production), with first gas targeted for Q4 2027.
Empyrean has eliminated funding risk on its flagship asset while preserving upside through a revenue-sharing structure. The removal of development capital calls and regulatory certainty materially de-risks the path to cash generation, though returns remain contingent on Mako reaching commercial production on schedule and realizing projected gas sales.
Insights assembled by AI. Editor-reviewed and grounded in tickstock’s coverage and proprietary knowledge graph.
Content is for informational purposes only, not financial advice.
